Corcept Therapeutics (CORT) Other Non-Current Assets (2010 - 2026)

Corcept Therapeutics (CORT) has 17 years of Other Non-Current Assets data on file, last reported at $5.2 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Assets fell 22.04% year-over-year to $5.2 million; the trailing twelve-month figure through Mar 2026 stood at $5.2 million (down 22.04% YoY), and the FY2025 full-year result was $5.2 million, down 22.04% from the prior year.
• Other Non-Current Assets steadied at $5.2 million in Q1 2026, from $5.2 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $8.3 million in Q2 2025 to a low of $1.8 million in Q2 2022.
• A 5-year average of $5.7 million and a median of $6.4 million in 2024 frame the typical range for Other Non-Current Assets.
• Across the five-year window, Other Non-Current Assets slumped 55.7% in 2022 and surged 140.62% in 2023, its largest moves.
• Tracing CORT's Other Non-Current Assets over 5 years: stood at $5.1 million in 2022, then grew by 29.32% to $6.5 million in 2023, then increased by 1.05% to $6.6 million in 2024, then retreated by 22.04% to $5.2 million in 2025, then changed by 0.0% to $5.2 million in 2026.
• Business Quant data shows CORT's Other Non-Current Assets at $5.2 million in Q1 2026, $5.2 million in Q4 2025, and $8.0 million in Q3 2025.